C82.5

Clinical Causes: Genetic mutations in B-lymphocytes Certain infections may influence immune system behavior, though no direct infectious cause is identified Age-related immune system decline, especially in middle-aged and older adults Potential exposure to specific environmental toxins or chemicals, though evidence is limited

Key Symptoms: Swelling of lymph nodes, often painless and appearing in areas such as the neck, armpits, or groin Unintentional weight loss Persistent fatigue or weakness Fever that is not caused by an infection Night sweats Abdominal discomfort or swelling if internal lymph nodes are involved Loss of appetite

Diagnosis Path: Diagnosing diffuse follicle center lymphoma involves multiple steps to confirm the presence and extent of the disease. This typically includes: - **Physical Examination:** A thorough check for enlarged lymph nodes or other signs of lymphatic involvement. - **Imaging Tests:** Such as CT scans, PET scans, or MRI to determine the spread and locations of lymphoma. - **Biopsy:** Removal of a lymph node or tissue sample for microscopic examination. Histopathology reveals characteristic features of follicle center cells. - **Immunohistochemistry:** Tests to identify specific markers on the malignant cells, confirming the diagnosis. - **Blood Tests:** To assess overall health status and organ function. Based on the findings, staging procedures are performed to determine whether the lymphoma is localized or disseminated, influencing treatment strategies.

Treatment Protocols: Management of diffuse follicle center lymphoma involves a combination of therapies, tailored to the stage and health of the patient: - **Chemotherapy:** Often includes drugs like rituximab combined with other chemotherapeutic agents to target and destroy cancerous cells. - **Immunotherapy:** Such as monoclonal antibodies directed against specific markers on lymphoma cells. - **Radiation therapy:** May be used in localized cases to eliminate residual disease. - **Targeted therapy:** Emerging treatments that specifically interfere with molecular pathways in lymphoma cells. - **Stem cell transplant:** Considered for more aggressive or refractory cases. Supportive care, including managing side effects and maintaining quality of life, is an essential component of treatment planning.